Halma PLC
HLMA
ISIN GB0004052071 / Valor 387465
Halma PLC
UMushroom community rating:
About company
Halma PLC is a diversified global group specializing in developing and delivering technology solutions aimed at enhancing safety, health, and environmental protection. The company operates through various subsidiaries, each focusing on specific niches within its broad mission. Alicat Scientific, one of its subsidiaries, is known for its high-precision flow and pressure devices that find applications in medical, scientific, and industrial settings. Another subsidiary, Fortress Interlocks, is recognized for its safety equipment designed to safeguard workers in hazardous environments. Additionally, Halma ventures into the healthcare technology sector through Perigen, which offers artificial intelligence-based early warning systems to improve outcomes for mothers and babies during childbirth. These examples illustrate Halma's commitment to leveraging technology across diverse sectors to promote safety, health, and well-being on a global scale.
Summarized from source with an LLMView SourceSector: TechnologyLatest Results (12.11.2025):
Halma PLC reported its Full Year Results for 2024/25, covering the 12 months ending 31 March 2025. The report highlights record revenue and profit growth across its diverse sectors, underpinned by strong cash performance, robust margins, and continued strategic investments that set the stage for future growth, even amid a challenging economic and geopolitical environment.
Record Revenue & Profit Growth
The Group achieved record revenue with an 11% increase to £2,248.1m, and adjusted EBIT rose by 15%, marking 22 consecutive years of profit growth alongside 46 years of dividend increases of 5% or more.
Diverse Sector Performance
Safety and Environmental & Analysis sectors both delivered broad-based revenue and profit growth, with the latter experiencing an exceptional 18% revenue increase. Healthcare showed modest revenue gains but improved notably in the second half of the year.
Operational Efficiency & Financial Strength
The adjusted EBIT margin improved by 80bps to 21.6%, and the Group achieved a robust cash conversion of 112%, with the return on total invested capital rising to 15.0%. Net debt/EBITDA was also reduced significantly, maintaining strong balance sheet discipline.
Strategic Investments & Forward Outlook
Halma PLC continued to invest in R&D and completed several acquisitions, positioning itself well for future growth. The outlook for the 2026 financial year remains positive with a strong order book and expectations of upper single digit organic revenue growth amid ongoing market challenges.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
16654 M
Market cap (USD)
459,114
Daily traded volume (Shares)
27.02 / 26.67
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
